+91 94997 68112
Login
Register
Home
About
Products
Para IV Insights
GenUS
Pharmalysis
Services
Consulting
Free Reports
Periodic Reports
Special Reports
Career
Media coverage
Contact
Periodic Reports
Home
Report
Subscribe to free reports on USFDA activities – much more than what you get in USFDA
Archive
2024
Mar 2024
Feb 2024
Jan 2024
2023
Dec 2023
Nov 2023
Oct 2023
Sep 2023
Aug 2023
Generic Launches March 2024
Sun Mar, 2024 | Periodic
Generic Approvals of Discontinued NDAs March 2024
Sun Mar, 2024 | Periodic
ANDA Approval of Additional Strength March 2024
Sun Mar, 2024 | Periodic
Change of Marketing Status from Discontinued to Prescription March 2024
Sun Mar, 2024 | Periodic
Tentative Approvals Converted to Final Approvals March 2024
Sun Mar, 2024 | Periodic
Tentative Approvals Converted to Final Approvals February 2024
Thu Feb, 2024 | Periodic
Change of Marketing Status from Discontinued to Prescription February 2024
Thu Feb, 2024 | Periodic
ANDA Approval of Additional Strength February 2024
Thu Feb, 2024 | Periodic
Generic Approvals of Discontinued NDAs February 2024
Thu Feb, 2024 | Periodic
Generic Launches February 2024
Thu Feb, 2024 | Periodic
Generic Approvals of Discontinued NDAs January 2024
Wed Jan, 2024 | Periodic
Generic Launches January 2024
Wed Jan, 2024 | Periodic
ANDA Approval of Additional Strength January 2024
Wed Jan, 2024 | Periodic
Change of Marketing Status from Discontinued to Prescription January 2024
Wed Jan, 2024 | Periodic
Tentative Approvals Converted to Final Approvals January 2024
Wed Jan, 2024 | Periodic
Generic Launches December 2023
Sun Dec, 2023 | Periodic
Generic Approvals of Discontinued NDAs December 2023
Sun Dec, 2023 | Periodic
ANDA Approval of Additional Strength December 2023
Sun Dec, 2023 | Periodic
Change of Marketing Status from Discontinued to Prescription December 2023
Sun Dec, 2023 | Periodic
Tentative Approvals Converted to Final Approvals December 2023
Sun Dec, 2023 | Periodic
Generic Approvals of Discontinued NDAs November 2023
Thu Nov, 2023 | Periodic
ANDA Approval of Additional Strength November 2023
Thu Nov, 2023 | Periodic
Change of Marketing Status from Discontinued to Prescription November 2023
Thu Nov, 2023 | Periodic
Tentative Approvals Converted to Final Approvals November 2023
Thu Nov, 2023 | Periodic
Generic Launches October 2023
Tue Oct, 2023 | Periodic
Generic Approvals of Discontinued NDAs October 2023
Tue Oct, 2023 | Periodic
ANDA Approval of Additional Strength October 2023
Tue Oct, 2023 | Periodic
Change of Marketing Status from Discontinued to Prescription October 2023
Tue Oct, 2023 | Periodic
Tentative Approvals Converted to Final Approvals October 2023
Tue Oct, 2023 | Periodic
Generic Launches September 2023
Sat Sep, 2023 | Periodic
Generic Approvals of Discontinued NDAs September 2023
Sat Sep, 2023 | Periodic
ANDA Approval of Additional Strength September 2023
Sat Sep, 2023 | Periodic
Change of Marketing Status from Discontinued to Prescription September 2023
Sat Sep, 2023 | Periodic
Tentative Approvals Converted to Final Approvals September 2023
Sat Sep, 2023 | Periodic
Tentative Approvals Converted to Final Approvals August 2023
Thu Aug, 2023 | Periodic
Generic Launches August 2023
Thu Aug, 2023 | Periodic
Generic Approvals of Discontinued NDAs August 2023
Thu Aug, 2023 | Periodic
ANDA Approval of Additional Strength August 2023
Thu Aug, 2023 | Periodic
Change of Marketing Status from Discontinued to Prescription August 2023
Thu Aug, 2023 | Periodic
Subscription
Tentative Approval to Final Approval
Generics Approvals Discontinued
New Strength Approval for Existing Product
New Approvals for Discontinued NDA
Generic Launches
Login To SUBSCRIBE
